跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 362 条关于
“isocitrate dehydrogenase”
全部
362
临床试验
160
药物
40
机构
0
资讯
162
2年前
FDA Approves Vorasidenib (Voranigo) for IDH-Mutant Grade 2 Glioma
去年
CDSCO Panel Recommends Approval for Vorasidenib with Phase-III Waiver for IDH-Mutant Gliomas in India
去年
European Regulators Recommend Approval of Vorasidenib for IDH-Mutant Grade 2 Glioma
9个月前
Robust AML Clinical Pipeline Shows Promise with 100+ Companies Developing Novel Therapies
去年
Agios Pharma Shares Rise as FDA Grants Breakthrough Status to Thermo Fisher's Glioma Test
去年
Eflornithine Combo Fails to Meet Primary Endpoint in Phase III Brain Cancer Trial
去年
FDA Approves Vorasidenib as Targeted Therapy for IDH-Mutant Gliomas
2年前
Rigel Pharmaceuticals Initiates Phase Ib/II Trial of REZLIDHIA Combination Therapy for mIDH1 AML
2年前
FDA Approves Vorasidenib (Voranigo) for IDH-Mutant Glioma, Developed from Duke Neurosurgeon's Discovery
3年前
FDA Approves Olutasidenib for Relapsed or Refractory AML with IDH1 Mutation
第 1 页,共 17 页
上一页
下一页